AAAAAA

   
Results: 1-20 |
Results: 20
PHARMACOLOGICAL PROFILING OF PHOSPHODIESTERASE-4 (PDE4) INHIBITORS AND ANALYSIS OF THE THERAPEUTIC RATIO IN RATS AND DOGS
Authors: ESCOTT KJ MCMILLAN SJ BIRRELL M WEBBER SE SOUNESS JE MASLEN C TEMPLE R IQBAL S MARIUCCI M ROSE J GEIGER LE THURAIRATNAM S BOWER S ALDOUS D SARGENT CA
Citation: Kj. Escott et al., PHARMACOLOGICAL PROFILING OF PHOSPHODIESTERASE-4 (PDE4) INHIBITORS AND ANALYSIS OF THE THERAPEUTIC RATIO IN RATS AND DOGS, British Journal of Pharmacology, 123, 1998, pp. 40-40
THE CHALLENGE OF REGULATING DEVELOPMENT AND APPROVAL DRUGS WITH PLEIOTROPIC ACTION IN CARDIOVASCULAR-DISEASE
Authors: TEMPLE R
Citation: R. Temple, THE CHALLENGE OF REGULATING DEVELOPMENT AND APPROVAL DRUGS WITH PLEIOTROPIC ACTION IN CARDIOVASCULAR-DISEASE, The American journal of cardiology, 81(8A), 1998, pp. 5-8
EXAMINATION OF INTEREST INVENTORIES BASED ON ROES CLASSIFICATION
Authors: MEIR EI RUBIN A TEMPLE R OSIPOW SH
Citation: Ei. Meir et al., EXAMINATION OF INTEREST INVENTORIES BASED ON ROES CLASSIFICATION, The Career development quarterly, 46(1), 1997, pp. 48-61
CLINICAL-TRIAL INVESTIGATORS TALK ABOUT GETTING THE DATA - DISCUSSION
Authors: MARWICK C HARLAN WR ABERNETHY D TEMPLE R
Citation: C. Marwick et al., CLINICAL-TRIAL INVESTIGATORS TALK ABOUT GETTING THE DATA - DISCUSSION, JAMA, the journal of the American Medical Association, 277(23), 1997, pp. 1833-1836
TEMPORAL DECLINE IN FILLING PRESCRIPTIONS FOR TERFENADINE CLOSELY IN TIME WITH THOSE FOR EITHER KETOCONAZOLE OR ERYTHROMYCIN
Authors: BURKHART GA SEVKA MJ TEMPLE R HONIG PK
Citation: Ga. Burkhart et al., TEMPORAL DECLINE IN FILLING PRESCRIPTIONS FOR TERFENADINE CLOSELY IN TIME WITH THOSE FOR EITHER KETOCONAZOLE OR ERYTHROMYCIN, Clinical pharmacology and therapeutics, 61(1), 1997, pp. 93-96
THE 6TH REPORT OF THE ,-EVALUATION,-AND-TREATMENT-OF-HIGH-BLOOD-PRESSURE
Authors: BLACK HR COHEN JD KAPLAN NM FERDINAND KC CHOBANIAN AV DUSTAN HP GIFFORD RW MOSER M SHEPS SG AGODOA L AUGUST PA BAKRIS GL BURT V BUSSE W CARTER BL CHESLEY FD CLEEMAN J COHN JN CREGLER LL CRESPO C CUSHMAN WC CUTLER J DARROW MD DEQUATTRO VL DEVEREUX RB DWORKIN LD ELLIOTT WJ EPSTEIN M FALKNER B FERRARIO CM FLACK JM FRISHMAN W FROHLICH ED GREEN LA GRIMM RH HAGBERG JM HALL WD HANDLER J HAVAS S HILL MN HORAN MJ HSUEH WA HYMAN BN IZZO JL JAMERSON K KILEY JP KOCHAR MS KOLASA KM KRAKOFF LR LEVY D LINDHEIMER MD LUEPKER RV MALONE MEL MASSIE B MATERSON BJ MERCHANT J MESSERLI FH MILLER NH MOORE MA MUSTONEALEXANDER L OPARIL S PERRY HM PICKERING TG PRATT JH RAM CVS RANDALL OS REED JW ROBERTS RW ROCCELLA EJ ROGUS SD SAUNDERS E SCHRON E SCHWARTZ G SIBAI BM SNYDER D SOWERS JR STAMLER J TEMPLE R TEXTOR S THOM T VIDT DG WEBER M WEINBERGER MH WEINSHILBOUM R WHELTON PK WHISNANT JP WIEBERS DO WINSTON MC WRIGHT JT LENFANT C CASSER L COLMAN PJ EDWARDS T FEELEY DM GAJEWSKI J LEVINE D MANGER W MARSHALL EC NICKEY WA ROBERT RW SECREST BG SINGER EH WHISNANT JP WILSON GJ YOUNG JM BACHMAN JW CAMPESE VM CARR AA HAND M HOLDEN DC JAMIESON MJ JULIUS S MENSAH GA PRISANT M SULLIVAN JM WILSON DJ MOROSCO G ANDERSON DE WAUGH D
Citation: Hr. Black et al., THE 6TH REPORT OF THE ,-EVALUATION,-AND-TREATMENT-OF-HIGH-BLOOD-PRESSURE, Archives of internal medicine, 157(21), 1997, pp. 2413-2446
WHY WOULD ANYONE HAVE EXPECTED ANYTHING ELSE - CHARACTERISTICS OF MATERIALS DISTRIBUTED BY DRUG COMPANIES - 4 POINTS-OF-VIEW
Authors: TEMPLE R OBRIEN P
Citation: R. Temple et P. Obrien, WHY WOULD ANYONE HAVE EXPECTED ANYTHING ELSE - CHARACTERISTICS OF MATERIALS DISTRIBUTED BY DRUG COMPANIES - 4 POINTS-OF-VIEW, Journal of general internal medicine, 11(10), 1996, pp. 640-641
THE BROTHERHOOD-OF-THE-COMMON-LIFE AND ITS INFLUENCE - FULLER,R
Authors: TEMPLE R
Citation: R. Temple, THE BROTHERHOOD-OF-THE-COMMON-LIFE AND ITS INFLUENCE - FULLER,R, Parabola, 21(1), 1996, pp. 116
APPROVAL OF NEW DRUGS IN THE UNITED-STATES - COMPARISON WITH THE UNITED-KINGDOM, GERMANY, AND JAPAN
Authors: KESSLER DA HASS AE FEIDEN KL LUMPKIN M TEMPLE R
Citation: Da. Kessler et al., APPROVAL OF NEW DRUGS IN THE UNITED-STATES - COMPARISON WITH THE UNITED-KINGDOM, GERMANY, AND JAPAN, JAMA, the journal of the American Medical Association, 276(22), 1996, pp. 1826-1831
THE ARCHITECTURE OF GOVERNMENT-REGULATION OF MEDICAL PRODUCTS - COMMENTARY
Authors: TEMPLE R
Citation: R. Temple, THE ARCHITECTURE OF GOVERNMENT-REGULATION OF MEDICAL PRODUCTS - COMMENTARY, Virginia law review, 82(8), 1996, pp. 1877-1906
FRENCH GENERATIVE PHONOLOGY - RETROSPECTIVE AND PERSPECTIVES - LYCHE,C
Authors: TEMPLE R
Citation: R. Temple, FRENCH GENERATIVE PHONOLOGY - RETROSPECTIVE AND PERSPECTIVES - LYCHE,C, French studies, 50(4), 1996, pp. 495-496
REVISED FDA LABELING GUIDELINE FOR THEOPHYLLINE ORAL DOSAGE FORMS
Authors: HENDELES L JENKINS J TEMPLE R
Citation: L. Hendeles et al., REVISED FDA LABELING GUIDELINE FOR THEOPHYLLINE ORAL DOSAGE FORMS, Pharmacotherapy, 15(4), 1995, pp. 409-427
WOMEN IN CLINICAL-TRIALS - AN FDA PERSPECTIVE
Authors: SHERMAN LA TEMPLE R MERKATZ RB
Citation: La. Sherman et al., WOMEN IN CLINICAL-TRIALS - AN FDA PERSPECTIVE, Science, 269(5225), 1995, pp. 793-795
ANCIENT INVENTIONS - JAMES,P, THORPE,N
Authors: TEMPLE R
Citation: R. Temple, ANCIENT INVENTIONS - JAMES,P, THORPE,N, Nature, 374(6521), 1995, pp. 418-419
AM I THE INNKEEPER + THE PAINTINGS OF BRUEGHEL,PIETER THE ELDER
Authors: TEMPLE R
Citation: R. Temple, AM I THE INNKEEPER + THE PAINTINGS OF BRUEGHEL,PIETER THE ELDER, Parabola, 19(4), 1994, pp. 66-70
WOMEN IN CLINICAL-TRIALS OF NEW DRUGS - A CHANGE IN FOOD-AND-DRUG-ADMINISTRATION POLICY
Authors: MERKATZ RB TEMPLE R SOBEL S FEIDEN K KESSLER DA
Citation: Rb. Merkatz et al., WOMEN IN CLINICAL-TRIALS OF NEW DRUGS - A CHANGE IN FOOD-AND-DRUG-ADMINISTRATION POLICY, The New England journal of medicine, 329(4), 1993, pp. 292-296
FDA POLICY ON WOMEN IN DRUG TRIALS - REPLY
Authors: KESSLER DA MERKATZ RB TEMPLE R
Citation: Da. Kessler et al., FDA POLICY ON WOMEN IN DRUG TRIALS - REPLY, The New England journal of medicine, 329(24), 1993, pp. 1815-1816
MORE ON THE SURVIVAL AND VENTRICULAR ENLARGEMENT TRIAL
Authors: GANLEY CJ HUNG HMJ TEMPLE R
Citation: Cj. Ganley et al., MORE ON THE SURVIVAL AND VENTRICULAR ENLARGEMENT TRIAL, The New England journal of medicine, 329(16), 1993, pp. 1204-1205
THE RESULTS OF EFFORTS TO IMPROVE COMPLIANCE WITH SUPPORTIVE PERIODONTAL TREATMENT IN A PRIVATE-PRACTICE
Authors: WILSON TG HALE S TEMPLE R
Citation: Tg. Wilson et al., THE RESULTS OF EFFORTS TO IMPROVE COMPLIANCE WITH SUPPORTIVE PERIODONTAL TREATMENT IN A PRIVATE-PRACTICE, Journal of periodontology, 64(4), 1993, pp. 311-314
WORK ABSENTEEISM, DISABILITY AND HEALTH-CARE USE IN A NATIONAL SAMPLEOF PERSONS WITH FUNCTIONAL GI DISORDERS
Authors: DROSSMAN DA LI Z ANDRUZZI E TEMPLE R
Citation: Da. Drossman et al., WORK ABSENTEEISM, DISABILITY AND HEALTH-CARE USE IN A NATIONAL SAMPLEOF PERSONS WITH FUNCTIONAL GI DISORDERS, Gastroenterology, 104(4), 1993, pp. 499-499
Risultati: 1-20 |